Kj Laboratories (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 62.44%
- Profit Growth 24.60%
- Ebitda 28.48%
- Net Worth 37.46%
- Total Assets 89.36%
About Kj Laboratories (Opc)
Kj Laboratories (Opc) Private Limited (KLOPL) is a Company incorporated in India on 02 August 2016 (Eight years and six months 15 days old ). Its registered office is in Kaushambi, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipin Singh serves as a director at the Company.
Company Details
-
Location
Kaushambi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2016OPC085349
-
Company No.
085349
-
Incorporation Date
02 Aug 2016
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Kj Laboratories (Opc) Private Limited offer?
Kj Laboratories (Opc) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Anti Infective Drugs & Medicines, Antibiotic Injection, Nutritional Supplements, Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Antihistamines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Kj Laboratories (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Singh
|
Director | 02-Aug-2016 | Current |
Financial Performance of Kj Laboratories (Opc).
Kj Laboratories (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 62.44% increase. The company also saw a substantial improvement in profitability, with a 24.6% increase in profit. The company's net worth Soared by an impressive increase of 37.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kj Laboratories (Opc)?
In 2020, Kj Laboratories (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kj Laboratories (Opc)?
Unlock and access historical data on people associated with Kj Laboratories (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kj Laboratories (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kj Laboratories (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
